p53 and MYC-regulated squalene epoxidase as Achilles heel in colorectal cancer

被引:0
|
作者
Fischer, Martin [1 ]
机构
[1] Fritz Lipmann Inst FLI, Leibniz Inst Aging, Computat Biol Grp, Beutenbergstr 11, D-07745 Jena, Germany
来源
关键词
tumor suppressor p53; transcription factor MYC; SQLE; cholesterol synthesis; Terbinafine; colorectal cancer;
D O I
10.7150/ijbs.89237
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The transcription factors p53 and MYC are often considered non-druggable targets, but their dysregulation can generate new dependencies and treatment opportunities in cancer cells. The p53 and MYC-regulated squalene epoxidase (SQLE) has been identified as a potential Achilles heel in colorectal cancer. This is of great interest because the FDA-approved anti-fungal SQLE inhibitor Terbinafine could be repurposed to treat colorectal cancer patients.
引用
收藏
页码:4831 / 4832
页数:2
相关论文
共 50 条
  • [21] A squalene epoxidase-cholesterolaxis drives colorectal cancer progression and metastatic dissemination
    Jun, Soo Young
    Brown, Andrew J.
    Yoon, Ji-Yong
    Lee, Jeong-Ju
    Chua, Ngee Kiat
    Yang, Jin O. K.
    Min, Ju-Sik
    Jang, Insu
    Jeon, Su-Jin
    Choi, Min-Hyuk
    Choi, Tae-Ik
    Kim, Cheol-Hee
    Kim, Nam-Soon
    CANCER RESEARCH, 2019, 79 (13)
  • [22] Overexpression of p53 mRNA in colorectal cancer and its relationship to p53 gene mutation
    ElMahdani, N
    Vaillant, JC
    Guiguet, M
    Prevot, S
    Bertrand, V
    Bernard, C
    Parc, R
    Bereziat, G
    Hermelin, B
    BRITISH JOURNAL OF CANCER, 1997, 75 (04) : 528 - 536
  • [23] Overexpression of p53 mRNA in colorectal cancer and its relationship to p53 gene mutation
    N el-Mahdani
    J-C Vaillant
    M Guiguet
    S Prévot
    V Bertrand
    C Bernard
    R Parc
    G Béréziat
    B Hermelin
    British Journal of Cancer, 1997, 75 : 528 - 536
  • [24] A polymorphic MYC response element in KBTBD11 influences colorectal cancer risk, especially in interaction with an MYC-regulated SNP rs6983267
    Gong, J.
    Tian, J.
    Lou, J.
    Wang, X.
    Ke, J.
    Li, J.
    Yang, Y.
    Gong, Y.
    Zhu, Y.
    Zou, D.
    Peng, X.
    Yang, N.
    Mei, S.
    Zhong, R.
    Chang, J.
    Miao, X.
    ANNALS OF ONCOLOGY, 2018, 29 (03) : 632 - 639
  • [25] Reduction of Squalene Epoxidase by Cholesterol Accumulation Accelerates Colorectal Cancer Progression and Metastasis
    Jun, Soo Young
    Brown, Andrew J.
    Chua, Ngee Kiat
    Yoon, Ji-Yong
    Lee, Jeong-Ju
    Yang, Jin Ok
    Jang, InSu
    Jeon, Su-Jin
    Choi, Tae-Ik
    Kim, Cheol-Hee
    Kim, Nam-Soon
    GASTROENTEROLOGY, 2021, 160 (04) : 1194 - +
  • [26] p53 autoantibodies in sera of patients with a colorectal cancer and their association to p53 protein concentration and p53 immunohistochemistry in tumor tissue
    R. Broll
    M. Duchrow
    E. Oevermann
    C. Wellm
    O. Schwandner
    H. Schimmelpenning
    U.J. Roblick
    H.P. Bruch
    U. Windhövel
    International Journal of Colorectal Disease, 2001, 16 : 22 - 27
  • [27] p53 autoantibodies in sera of patients with a colorectal cancer and their association to p53 protein concentration and p53 immunohistochemistry in tumor tissue
    Broll, R
    Duchrow, M
    Oevermann, E
    Wellm, C
    Schwandner, O
    Schimmelpenning, H
    Roblick, UJ
    Bruch, HP
    Windhövel, U
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2001, 16 (01) : 22 - 27
  • [28] Cytoplasmic retention of p53 in colorectal cancer cells
    Milicevic, ZT
    Petrovic, MV
    Mihailovic, MV
    Bogojevic, DB
    FEBS JOURNAL, 2005, 272 : 127 - 128
  • [29] SCREENING FOR P53 MUTATIONS IN COLORECTAL-CANCER
    TRIANTAFILLOU, N
    MACERA, MJ
    SMITH, LJ
    NEWMAN, L
    EARLE, D
    GROSMAN, I
    VERMA, RS
    AMERICAN JOURNAL OF HUMAN GENETICS, 1995, 57 (04) : 1764 - 1764
  • [30] Socioeconomic status, p53 abnormalities, and colorectal cancer
    Vogtmann, Emily
    Shanmugam, Chandrakumar
    Katkoori, Venkat R.
    Waterbor, John
    Manne, Upender
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2013, 4 (01) : 40 - 44